Dementia - McKnight's Long Term Care News

Dementia

Generic oblong pills

Stable LTC antipsychotic prescribing in 2020 may reflect success of U.S. reduction initiatives

University of Michigan researchers have found relatively minimal changes in central nervous system-active medication use among Michigan nursing home residents with dementia following the start of the COVID-19 pandemic, a finding that may be explained in part by regulatory pressures to reduce antipsychotic prescribing in U.S. skilled nursing facilities.  With the disruptions in daily routines…

Clinical briefs for Tuesday, April 6

COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral that wipes out all flu viruses … 20% of healthcare workers say they’ve considered leaving job due to pandemic-related worries: survey … Parkinson’s disease symptoms tied to distinct brain pathways … 13 new Alzheimer’s genes identified in first-of-its-kind human genome study

Dementia-related psychosis featured in March 24 webinar

Looking to better understand how dementia-related psychosis might affect residents? Broaden your perspective during a McKnight’s disease-awareness webinar providing an overview of hallucinations and delusions associated with dementia-related psychosis from the long-term care perspective. The program will focus on the prevalence, impact and proposed neurobiology of hallucinations and delusions across the dementias, as well as…

Next post in Webinars